Ex vivo and in vitro inhibitory potential of Kava extract on monoamine oxidase B activity in mice
- PMID: 35528470
- PMCID: PMC9072822
- DOI: 10.1016/j.jtcme.2021.07.002
Ex vivo and in vitro inhibitory potential of Kava extract on monoamine oxidase B activity in mice
Abstract
Background and aim: This study investigated the effect of Kava extract (Piper methysticum), a medicinal plant that has been worldly used by its anxiolytic effects, on monoamine oxidase (MAO) activity of mice brain after 21 days of treatment as well as anxiolytic and locomotor behavior. Furthermore, the in vitro inhibitory profile of Kava extract on MAO-B activity of mouse brain was evaluated.
Experimental procedure: Mice were treated with Kava extract (10, 40, 100 and 400 mg/kg) for 21 days by gavage. After behavioral analysis (plus maze test and open field), MAO activity in different mouse brain structures (cortex, hippocampus, region containing the substantia nigra and striatum) were performed. MAO-B inhibitory profile was characterized in vitro.
Results: The treatment with Kava extract (40 mg/kg) increased the percentage of entries of mice into the open arms. Ex vivo analysis showed an inhibition on MAO-B activity caused by Kava extract in cortex (10 mg/kg) and in the region containing the substantia nigra (10 and 100 mg/kg). In vitro, Kava extract also reversibly inhibited MAO-B activity with IC50 = 14.62 μg/mL and, increased Km values at the concentrations of 10 and 30 μg/mL and decreased Vmax value at 100 μg/mL.
Conclusion: Kava extract showed different effects on MAO-B isoform depending on the brain structure evaluated. Therefore, the use of Kava extract could be promissory in pathologies where MAO-B is the pharmacological target.
Keywords: 4-HQ, 4-hydroxyquinoline; 5-HT, serotonin; AMPH, amphetamine; Anxiety; CEUA, Ethic Committee on Animal Use; CNS, central nervous system; CONCEA, National Council of Control of Animal Experimentation; DA, dopamine; GABA, gamma-aminobutyric acid; HPLC, High performance liquid chromatography; Kynuramine; MAO, Monoamine oxidase; NE, norepinephrine; Open field; Piper methysticum; Plus maze.
© 2021 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC.
Conflict of interest statement
All authors declare there are no potential financial, personal, or otherwise conflicts of interest.
Figures





Similar articles
-
Kava decreases the stereotyped behavior induced by amphetamine in mice.J Ethnopharmacol. 2021 Jan 30;265:113293. doi: 10.1016/j.jep.2020.113293. Epub 2020 Aug 22. J Ethnopharmacol. 2021. PMID: 32841698
-
Monoamine Oxidase Inhibition by Kavalactones from Kava (Piper Methysticum).Planta Med. 2019 Oct;85(14-15):1136-1142. doi: 10.1055/a-1008-9491. Epub 2019 Sep 20. Planta Med. 2019. PMID: 31539917
-
Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).Pharmacopsychiatry. 1998 Sep;31(5):187-92. doi: 10.1055/s-2007-979325. Pharmacopsychiatry. 1998. PMID: 9832350
-
Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.J Ethnopharmacol. 2021 Mar 25;268:113582. doi: 10.1016/j.jep.2020.113582. Epub 2020 Nov 12. J Ethnopharmacol. 2021. PMID: 33189846 Review.
-
Kava: a comprehensive review of efficacy, safety, and psychopharmacology.Aust N Z J Psychiatry. 2011 Jan;45(1):27-35. doi: 10.3109/00048674.2010.522554. Epub 2010 Nov 15. Aust N Z J Psychiatry. 2011. PMID: 21073405 Review.
Cited by
-
An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava.J Clin Med. 2022 Jul 12;11(14):4039. doi: 10.3390/jcm11144039. J Clin Med. 2022. PMID: 35887801 Free PMC article. Review.
-
Screening tools to evaluate the neurotoxic potential of botanicals: building a strategy to assess safety.Expert Opin Drug Metab Toxicol. 2024 Jul;20(7):629-646. doi: 10.1080/17425255.2024.2378895. Epub 2024 Jul 22. Expert Opin Drug Metab Toxicol. 2024. PMID: 38984683 Free PMC article. Review.
-
Prolonged Serotonergic Symptoms in a Pediatric Patient: Suspected Interaction Between Prescription Medications and Kava Supplement.Cureus. 2025 May 12;17(5):e83966. doi: 10.7759/cureus.83966. eCollection 2025 May. Cureus. 2025. PMID: 40510098 Free PMC article.
-
Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder.Nutrients. 2023 Oct 28;15(21):4586. doi: 10.3390/nu15214586. Nutrients. 2023. PMID: 37960239 Free PMC article. Clinical Trial.
References
-
- Sarris J., Scholey A., Schweitzer I., et al. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study. Hum Psychopharmacol. 2012;27(3):262–269. - PubMed
-
- Jamieson D.D., Duffield P.H. The antinociceptive actions of kava components IN mice. Clin Exp Pharmacol Physiol. 1990;17(7):495–507. - PubMed
-
- Cairney S., Maruff P., Clough A.R. The neurobehavioural effects of kava. Aust N Z J Psychiatr. 2002;36(5):657–662. - PubMed
LinkOut - more resources
Full Text Sources